The Abu Dhabi Stem Cells Center and Yas Clinic are the first in the UAE to receive AABB accreditation for Hematopoietic Progenitor Cell Collection, underscoring their commitment to quality in cellular therapy. This achievement reinforces their status as leaders in regenerative medicine within the MENA region, backed by extensive clinical expertise and advanced facilities.
The Abu Dhabi Stem Cells Center (ADSCC) and Yas Clinic have achieved significant recognition as the first institutions in the UAE to receive AABB accreditation for Hematopoietic Progenitor Cell Collection. This prestigious global accreditation marks them as the second facility in the MENA region to meet stringent quality and safety standards for the procurement, processing, and storage of these essential cells used in transplantation and treatment of blood disorders.
As Centers of Excellence in Hematopoietic Stem Cell Transplantation, both ADSCC and Yas Clinic are already accredited by the Department of Health Abu Dhabi and the Foundation for Accreditation of Cellular Therapy (FACT). Their successful acquisition of three accreditations for cellular therapies within a span of 24 months showcases their deep commitment to quality, safety, and innovation in patient care through their extensive programs, including CAR-T and Mesenchymal Stem Cells.
Prof. Yendry Ventura, CEO of ADSCC, expressed pride in their advancements, emphasizing their dedication to enhancing cellular therapy and medical innovation according to the UAE’s national healthcare agenda. He elaborated, “Achieving AABB accreditation marks a significant milestone in our commitment to excellence in cellular therapies. We continue to set new benchmarks in quality and patient safety, reinforced by our advanced infrastructure and unmatched clinical expertise.”
Dr. Maysoon Al Karam, Chief Medical Officer at Yas Clinic, highlighted the importance of this achievement, attributing it to the collective efforts of a dedicated team. She stated, “This accreditation positions ADSCC and Yas Clinic as a regional leader in bone marrow transplant and cellular therapy and reinforces our role in providing cutting-edge treatments.”
AABB’s accreditation program is recognized for promoting the highest standards of quality and safety in the fields of blood and biotherapies, ensuring care for patients and donors alike across all dimensions of transfusion medicine and biotherapies.
In conclusion, the Abu Dhabi Stem Cells Center and Yas Clinic’s AABB accreditation signifies a remarkable achievement in the UAE healthcare landscape. It highlights their dedication to maintaining superior standards in cellular therapy, establishing them as leaders in the region. These accomplishments not only benefit patient care but also bolster the advancement of medical practices in regenerative medicine on a global scale.
Original Source: www.mediaoffice.abudhabi
